Adenosine 2A receptor is protective against renal injury in MRL/lpr mice

Lupus

Volumn 20, Issue 7, 2011, Pages 667-677

  Zhang, L ^a   Yang, N ^a   Wang, S ^a   Huang, B ^a   Li, F ^a   Tan, H ^a   Liang, Y ^a   Chen, M ^a   Li, Y ^a   Yu, X ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

adenosine; glomerulonephritis; inflammation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; CREATININE; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; KIDNEY FUNCTION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SPLENOMEGALY; UREA BLOOD LEVEL; WESTERN BLOTTING;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED MRL LPR; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 79957591635     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310393262     Document Type: Article

References (29)

1. Bagavant H, Fu SM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol. 2009 ; 21: 489-494
2. Mok CC. Prognostic factors in lupus nephritis. Lupus. 2005 ; 14: 39-44 (Pubitemid 40216066)
3. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A. 1993 ; 90: 1756-1760 (Pubitemid 23069935)
4. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 ; 148: 1198-1215 (Pubitemid 9053639)
5. Sitkovsky MV, Lukashev D, Apasov S, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol. 2004 ; 22: 657-682 (Pubitemid 38680437)
6. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004 ; 25: 33-39 (Pubitemid 38032805)
7. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001 ; 41: 775-787 (Pubitemid 32385906)
8. Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol. 1985 ; 135: 1366-1371 (Pubitemid 16237462)
9. Okusa MD. A(2A) adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol. 2002 ; 282: F10-18
10. Csoka B, Himer L, Selmeczy Z, et al. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 2008 ; 22: 3491-3499
11. Zarek PE, Huang CT, Lutz ER, et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 2008 ; 111: 251-259
12. Weaver DR, Reppert SM. Adenosine receptor gene expression in rat kidney. Am J Physiol. 1992 ; 263: F991 - F995
13. Kreisberg MS, Silldorff EP, Pallone TL. Localization of adenosine receptor subtype mRNA in rat outer medullary descending vasa recta by RT-PCR. Am J Physiol. 1997 ; 272: H1231-1238
14. Pawelczyk T, Grden M, Rzepko R, Sakowicz M, Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol. 2005 ; 167: 315-325 (Pubitemid 43026089)
15. Sevigny CP, Li L, Awad AS, et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol. 2007 ; 178: 4240-4249 (Pubitemid 46492374)
16. Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol. 2006 ; 177: 2765-2769 (Pubitemid 44277790)
17. Muraoka M, Hasegawa H, Kohno M, et al. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum. 2006 ; 54: 3591-3600 (Pubitemid 44737171)
18. Anders HJ, Vielhauer V, Kretzler M, et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol. 2001 ; 12: 919-931 (Pubitemid 32378332)
19. Hasegawa H, Kohno M, Sasaki M, et al. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum. 2003 ; 48: 2555-2566 (Pubitemid 37129432)
20. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol. 2004 ; 286: G285-293
21. Garcia GE, Truong LD, Li P, et al. Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. FASEB J. 2008 ; 22: 445-454 (Pubitemid 351225581)
22. Wuthrich RP, Yui MA, Mazoujian G, Nabavi N, Glimcher LH, Kelley VE. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am J Pathol. 1989 ; 134: 45-51 (Pubitemid 19054977)
23. Banu N, Meyers CM. TGF-beta1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells. Kidney Int. 1999 ; 56: 985-994 (Pubitemid 29411725)
24. Lappas CM, Rieger JM, Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol. 2005 ; 174: 1073-1080 (Pubitemid 40094304)
25. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004 ; 18: 2195-2224
26. Kalergis AM, Iruretagoyena MI, Barrientos MJ, et al. Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology. 2009 ; 128: e306-314
27. Bshesh K, Zhao B, Spight D, et al. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol. 2002 ; 72: 1027-1036 (Pubitemid 35365178)
28. Sands WA, Martin AF, Strong EW, Palmer TM. Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transfer. Mol Pharmacol. 2004 ; 66: 1147-1159 (Pubitemid 39411055)
29. Varani K, Massara A, Vincenzi F, et al. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum. 2009 ; 60: 2880-2891